Related Experiment Video
Updated: Dec 28, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Comprehensive assessment of computational algorithms in predicting cancer driver mutations
Hu Chen1,2, Jun Li2, Yumeng Wang2
1Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX, 77030, USA.
Identifying cancer driver mutations is crucial for precision medicine. This study rigorously assessed 33 algorithms, finding that cancer-specific tools like CHASM and PrimateAI outperform general ones for prioritizing mutations.
Area of Science:
- Oncology
- Computational Biology
- Genomics
Background:
- Cancer initiation and evolution are driven by functional somatic mutations, termed driver mutations.
- Identifying these driver mutations in tumor cells is essential for precision cancer medicine.
- Numerous computational algorithms exist to predict missense variant effects, but their comparative performance is unassessed.
Purpose of the Study:
- To comprehensively assess the performance of computational algorithms for predicting cancer driver mutations.
- To provide insights into best practices for computationally prioritizing mutation candidates.
- To guide the development of future predictive algorithms.
Main Methods:
- Construction of five benchmark datasets including protein 3D structures, OncoKB annotations, TP53 mutation effects, xenograft tumor formation, and in vitro viability assays.
- Evaluation of 33 distinct computational algorithms using these datasets.
- Comparison of cancer-specific algorithms against general-purpose algorithms.
Main Results:
- CHASM, CTAT-cancer, DEOGEN2, and PrimateAI demonstrated superior performance compared to other evaluated algorithms.
- Cancer-specific algorithms significantly outperformed general-purpose algorithms in predicting driver mutations.
- Benchmark datasets were created to facilitate rigorous algorithm evaluation.
Conclusions:
- This study offers a comprehensive performance assessment of algorithms for predicting cancer driver mutations.
- Cancer-specific algorithms are recommended for prioritizing mutation candidates in clinical settings.
- Findings will inform end-users and guide the development of improved predictive tools.
Related Concept Videos
Cancer
Cancer Survival Analysis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Mutagenicity and Carcinogenicity
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

